BioNTech (BNTX) News Today $100.00 -1.93 (-1.89%) Closing price 04:00 PM EasternExtended Trading$100.00 0.00 (0.00%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BNTX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period APG Asset Management N.V. Boosts Holdings in BioNTech SE Sponsored ADR $BNTXAugust 29 at 5:06 AM | marketbeat.comBioNTech SE Sponsored ADR $BNTX Shares Sold by Aristides Capital LLCAugust 28 at 8:19 AM | marketbeat.comAltrinsic Global Advisors LLC Sells 6,727 Shares of BioNTech SE Sponsored ADR $BNTXAugust 28 at 7:54 AM | marketbeat.comBioNTech SE Sponsored ADR $BNTX Shares Acquired by HighTower Advisors LLCAugust 28 at 3:37 AM | marketbeat.comPfizer and BioNTech's COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19August 27 at 12:50 PM | businesswire.comPfizer and BioNTech's COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19August 27 at 12:50 PM | globenewswire.comT. Rowe Price Investment Management Inc. Grows Stock Holdings in BioNTech SE Sponsored ADR $BNTXAugust 27 at 4:49 AM | marketbeat.com42,000 Shares in BioNTech SE Sponsored ADR $BNTX Purchased by Erste Asset Management GmbHAugust 24, 2025 | marketbeat.comBioNTech SE Sponsored ADR $BNTX Shares Purchased by Charles Schwab Investment Management Inc.August 24, 2025 | marketbeat.comBioNTech’s Promising Phase III Study in Recurrent Endometrial CancerAugust 22, 2025 | msn.comCandriam S.C.A. Reduces Stock Position in BioNTech SE Sponsored ADR $BNTXAugust 22, 2025 | marketbeat.comCarmignac Gestion Trims Position in BioNTech SE Sponsored ADR $BNTXAugust 21, 2025 | marketbeat.comGroupama Asset Managment Acquires 109,819 Shares of BioNTech SE Sponsored ADR $BNTXAugust 21, 2025 | marketbeat.comBioNTech’s Promising Phase III Study on Recurrent Endometrial CancerAugust 20, 2025 | msn.comBioNTech’s New PDAC Study: A Potential Game-Changer in Cancer Treatment?August 19, 2025 | msn.comHealth Canada Approves Variant-Adapted Vaccine By BioNTech (BNTX)August 19, 2025 | finance.yahoo.comPfizer Canada, BioNTech get Health Canada approval for COVID variant vaccineAugust 19, 2025 | msn.comHC Wainwright Has Bearish Estimate for BioNTech Q3 EarningsAugust 19, 2025 | marketbeat.comHC Wainwright Analysts Lower Earnings Estimates for BioNTechAugust 19, 2025 | americanbankingnews.comBioNTech ADR Meets 80-Plus Relative Strength Rating BenchmarkAugust 18, 2025 | msn.comSei Investments Co. Lowers Position in BioNTech SE Sponsored ADR (NASDAQ:BNTX)August 18, 2025 | marketbeat.comInvesco Ltd. Has $58.75 Million Stake in BioNTech SE Sponsored ADR (NASDAQ:BNTX)August 18, 2025 | marketbeat.comSector Gamma AS Has $2.73 Million Stock Holdings in BioNTech SE Sponsored ADR (NASDAQ:BNTX)August 17, 2025 | marketbeat.comHC Wainwright Lowers BioNTech (NASDAQ:BNTX) Price Target to $136.00August 16, 2025 | marketbeat.comBioNTech’s Phase II Study on BNT327: A Potential Game-Changer in Lung Cancer TreatmentAugust 16, 2025 | msn.comBioNTech’s New Study on Breast Cancer Treatment: A Potential Game-Changer?August 16, 2025 | msn.comE Fund Management Co. Ltd. Invests $1.94 Million in BioNTech SE Sponsored ADR (NASDAQ:BNTX)August 15, 2025 | marketbeat.comDeutsche Bank AG Reduces Holdings in BioNTech SE Sponsored ADR (NASDAQ:BNTX)August 15, 2025 | marketbeat.comBioNTech’s BNT327 Trial: A New Hope for Small-cell Lung Cancer?August 14, 2025 | msn.comBioNTech’s Latest Clinical Study: A New Hope for Advanced Breast Cancer TreatmentAugust 14, 2025 | msn.comBioNTech Settles Patent Disputes with CureVac and GSKAugust 12, 2025 | theglobeandmail.comBioNTech’s Promising Trial: BNT113 and Pembrolizumab in Head and Neck CancerAugust 12, 2025 | msn.comGoldman Sachs Sticks to Its Hold Rating for BioNTech SE (BNTX)August 8, 2025 | theglobeandmail.comBioNTech (BNTX) Settles mRNA Patent Dispute with CureVac for US$370 MillionAugust 8, 2025 | finance.yahoo.comBioNTech SE (BNTX) Gets a Buy from Evercore ISIAugust 8, 2025 | theglobeandmail.comBioNTech SE Reports Strong Financial Results for Mid-2025August 8, 2025 | theglobeandmail.comBioNTech and Genmab’s GEN1056 Study: A New Hope for Advanced Tumor TreatmentAugust 8, 2025 | msn.comGSK provides update on U.S. settlement CureVac/BioNTech mRNA patent litigationAugust 8, 2025 | msn.comBioNTech SE (NASDAQ:BNTX) Just Released Its Second-Quarter Results And Analysts Are Updating Their EstimatesAugust 8, 2025 | finance.yahoo.comCureVac settles patent dispute litigation with Pfizer and BioNTechAugust 7, 2025 | reuters.comBioNTech SE Sponsored ADR (NASDAQ:BNTX) Shares Sold by Primecap Management Co. CAAugust 7, 2025 | marketbeat.comWells Fargo & Company Cuts BioNTech (NASDAQ:BNTX) Price Target to $150.00August 6, 2025 | marketbeat.comBioNTech (NASDAQ:BNTX) Stock Price Expected to Rise, Bank of America Analyst SaysAugust 6, 2025 | marketbeat.comBioNTech price target raised to $185 from $181 at Clear StreetAugust 5, 2025 | finance.yahoo.comThese Analysts Revise Their Forecasts On BioNTech After Q2 ResultsAugust 5, 2025 | benzinga.comBioNTech (BNTX) Reports Increased Sales And Reduced Losses In Q2 2025August 5, 2025 | finance.yahoo.comBioNTech (NASDAQ:BNTX) Issues Quarterly Earnings Results, Misses Estimates By $0.44 EPSAugust 5, 2025 | marketbeat.comTD Asset Management Inc Trims Stake in BioNTech SE Sponsored ADR (NASDAQ:BNTX)August 5, 2025 | marketbeat.comBioNTech SE (BNTX) Q2 2025 Earnings Call TranscriptAugust 4, 2025 | seekingalpha.comBioNTech SE 2025 Q2 - Results - Earnings Call PresentationAugust 4, 2025 | seekingalpha.com Get BioNTech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BNTX Media Mentions By Week BNTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BNTX News Sentiment▼1.421.03▲Average Medical News Sentiment BNTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BNTX Articles This Week▼1111▲BNTX Articles Average Week Get the Latest News and Ratings for BNTX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for BioNTech and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies GSK News Today Takeda Pharmaceutical News Today argenex News Today BeOne Medicines News Today Insmed News Today Teva Pharmaceutical Industries News Today Summit Therapeutics News Today Genmab A/S News Today Viatris News Today Dr. Reddy's Laboratories News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BNTX) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNTech SE Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access